Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Related structures:
AlphaFold database: A4HJK3
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006631 | fatty acid metabolic process | 4 | 2 |
GO:0006635 | fatty acid beta-oxidation | 6 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009062 | fatty acid catabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016042 | lipid catabolic process | 4 | 2 |
GO:0016054 | organic acid catabolic process | 4 | 2 |
GO:0019395 | fatty acid oxidation | 5 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0030258 | lipid modification | 4 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0034440 | lipid oxidation | 5 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044242 | cellular lipid catabolic process | 4 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044282 | small molecule catabolic process | 3 | 2 |
GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 19 |
GO:0004165 | delta(3)-delta(2)-enoyl-CoA isomerase activity | 5 | 12 |
GO:0016853 | isomerase activity | 2 | 19 |
GO:0016860 | intramolecular oxidoreductase activity | 3 | 12 |
GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 4 | 12 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 4 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 4 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 4 |
GO:0004300 | enoyl-CoA hydratase activity | 5 | 2 |
GO:0016829 | lyase activity | 2 | 2 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 2 |
GO:0016836 | hydro-lyase activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.305 |
CLV_NRD_NRD_1 | 309 | 311 | PF00675 | 0.210 |
CLV_NRD_NRD_1 | 341 | 343 | PF00675 | 0.610 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.543 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 297 | 299 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 311 | 313 | PF00082 | 0.211 |
CLV_PCSK_PC1ET2_1 | 311 | 313 | PF00082 | 0.211 |
CLV_PCSK_PC7_1 | 293 | 299 | PF00082 | 0.283 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.205 |
CLV_PCSK_SKI1_1 | 84 | 88 | PF00082 | 0.374 |
CLV_Separin_Metazoa | 294 | 298 | PF03568 | 0.193 |
CLV_Separin_Metazoa | 65 | 69 | PF03568 | 0.562 |
DEG_APCC_DBOX_1 | 297 | 305 | PF00400 | 0.290 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.616 |
DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.718 |
DOC_CYCLIN_RxL_1 | 237 | 248 | PF00134 | 0.301 |
DOC_MAPK_DCC_7 | 93 | 101 | PF00069 | 0.166 |
DOC_MAPK_gen_1 | 204 | 213 | PF00069 | 0.238 |
DOC_PP2B_LxvP_1 | 220 | 223 | PF13499 | 0.377 |
DOC_PP2B_LxvP_1 | 23 | 26 | PF13499 | 0.615 |
DOC_PP2B_LxvP_1 | 282 | 285 | PF13499 | 0.375 |
DOC_PP4_FxxP_1 | 167 | 170 | PF00568 | 0.304 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.606 |
DOC_USP7_UBL2_3 | 200 | 204 | PF12436 | 0.193 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.304 |
LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.403 |
LIG_14-3-3_CanoR_1 | 29 | 36 | PF00244 | 0.664 |
LIG_BRCT_BRCA1_1 | 99 | 103 | PF00533 | 0.297 |
LIG_deltaCOP1_diTrp_1 | 159 | 167 | PF00928 | 0.304 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.332 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.564 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.193 |
LIG_FHA_1 | 268 | 274 | PF00498 | 0.203 |
LIG_LIR_Apic_2 | 166 | 170 | PF02991 | 0.303 |
LIG_LIR_Gen_1 | 102 | 112 | PF02991 | 0.306 |
LIG_LIR_Gen_1 | 151 | 162 | PF02991 | 0.308 |
LIG_LIR_Gen_1 | 279 | 288 | PF02991 | 0.304 |
LIG_LIR_Gen_1 | 299 | 305 | PF02991 | 0.138 |
LIG_LIR_Gen_1 | 314 | 324 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 102 | 107 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 151 | 157 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 279 | 284 | PF02991 | 0.304 |
LIG_LYPXL_SIV_4 | 274 | 282 | PF13949 | 0.440 |
LIG_PCNA_PIPBox_1 | 327 | 336 | PF02747 | 0.375 |
LIG_PCNA_yPIPBox_3 | 327 | 340 | PF02747 | 0.327 |
LIG_Pex14_2 | 153 | 157 | PF04695 | 0.304 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 300 | 303 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 333 | 336 | PF00017 | 0.352 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.442 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.394 |
LIG_SH3_3 | 282 | 288 | PF00018 | 0.337 |
LIG_SH3_3 | 318 | 324 | PF00018 | 0.350 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.568 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.166 |
LIG_SUMO_SIM_par_1 | 97 | 102 | PF11976 | 0.365 |
LIG_SxIP_EBH_1 | 121 | 135 | PF03271 | 0.317 |
LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.426 |
LIG_TRAF2_1 | 156 | 159 | PF00917 | 0.293 |
LIG_TRAF2_1 | 265 | 268 | PF00917 | 0.475 |
LIG_WW_3 | 65 | 69 | PF00397 | 0.562 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.734 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.386 |
MOD_CK2_1 | 153 | 159 | PF00069 | 0.369 |
MOD_CMANNOS | 110 | 113 | PF00535 | 0.304 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.323 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.290 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.325 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.677 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.329 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.285 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.692 |
MOD_N-GLC_1 | 213 | 218 | PF02516 | 0.309 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.315 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.312 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.138 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.692 |
MOD_PK_1 | 280 | 286 | PF00069 | 0.403 |
MOD_PKA_1 | 311 | 317 | PF00069 | 0.212 |
MOD_PKA_1 | 68 | 74 | PF00069 | 0.615 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.212 |
MOD_PKA_2 | 311 | 317 | PF00069 | 0.212 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.447 |
MOD_Plk_2-3 | 267 | 273 | PF00069 | 0.329 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.322 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.304 |
MOD_SUMO_rev_2 | 116 | 123 | PF00179 | 0.402 |
TRG_DiLeu_BaEn_2 | 71 | 77 | PF01217 | 0.565 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.399 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.604 |
TRG_ER_diArg_1 | 296 | 298 | PF00400 | 0.307 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4C8 | Leptomonas seymouri | 71% | 98% |
A0A0N1PBS2 | Leptomonas seymouri | 31% | 100% |
A0A0S4IKH3 | Bodo saltans | 56% | 99% |
A0A0S4JA19 | Bodo saltans | 34% | 100% |
A0A1X0NRI1 | Trypanosomatidae | 53% | 93% |
A0A3Q8IE71 | Leishmania donovani | 35% | 100% |
A0A3S7X4R5 | Leishmania donovani | 76% | 100% |
A0A3S7X4T7 | Leishmania donovani | 74% | 100% |
A0A422N418 | Trypanosoma rangeli | 57% | 99% |
A0A422NUW6 | Trypanosoma rangeli | 31% | 100% |
A4HH09 | Leishmania braziliensis | 34% | 100% |
A4HJK8 | Leishmania braziliensis | 92% | 100% |
A4HJL5 | Leishmania braziliensis | 99% | 100% |
A4I438 | Leishmania infantum | 34% | 100% |
A4I708 | Leishmania infantum | 76% | 100% |
A4I738 | Leishmania infantum | 72% | 98% |
A9JS71 | Xenopus laevis | 27% | 100% |
C9ZKS4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
C9ZME0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 73% |
C9ZWP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 96% |
E9ADK3 | Leishmania major | 33% | 100% |
E9AE93 | Leishmania major | 24% | 100% |
E9AM78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9B226 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
E9B233 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 67% | 100% |
O34893 | Bacillus subtilis (strain 168) | 22% | 100% |
O35459 | Mus musculus | 24% | 100% |
P14604 | Rattus norvegicus | 25% | 100% |
P23965 | Rattus norvegicus | 36% | 100% |
P30084 | Homo sapiens | 25% | 100% |
P34559 | Caenorhabditis elegans | 24% | 100% |
P42125 | Mus musculus | 36% | 100% |
P42126 | Homo sapiens | 35% | 100% |
P76082 | Escherichia coli (strain K12) | 24% | 100% |
P95279 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 27% | 100% |
Q0AVM1 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 26% | 100% |
Q1ZXF1 | Dictyostelium discoideum | 28% | 100% |
Q3MIE0 | Rattus norvegicus | 26% | 100% |
Q3TLP5 | Mus musculus | 27% | 100% |
Q4Q628 | Leishmania major | 71% | 100% |
Q4Q636 | Leishmania major | 76% | 100% |
Q58DM8 | Bos taurus | 26% | 100% |
Q5R646 | Pongo abelii | 25% | 100% |
Q869N6 | Dictyostelium discoideum | 27% | 100% |
Q8BH95 | Mus musculus | 26% | 100% |
V5B2L9 | Trypanosoma cruzi | 54% | 88% |
V5BK92 | Trypanosoma cruzi | 34% | 100% |